Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $24.9B |
| Sales growthchange from the year before | +1.5% |
| Gross marginshare of sales left after the direct cost of what it sells | 39.9% |
| Operating marginshare of sales left after running the business | 18.6% |
| Net marginshare of sales kept as profit | 13.0% |
| Free-cash-flow marginspare cash generated per $100 of sales | 5.6% |
| Return on invested capitalprofit made on each $100 put into the business | 21.1% |
| Return on equityprofit vs. shareholders' accounting value | 69.1% |
| Debt / equitydebt vs. shareholders' accounting value | 2.68 |
| Interest coverhow many times profit covers interest payments | 10.3x |
| Change in share countnegative = the company is buying back its shares | -2.0% |
4 insiders sold $3.6M on the open market.
| Banovetz John PatrickExecutive Vice President | SoldJul 23 | 7,880 shat $170.44 · $1.3M |
| Reinseth Theresa ESr Vice President & CAO | SoldJul 23 | 924 shat $169.42 · $157K |
| Goralski Christian T JRGroup President | SoldJul 22 | 4,902 shat $170.46 · $836K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy